Inspire Medical Systems, Inc. (NYSE:INSP) management will conduct a conference call for 4th August 2020 at 5:00 PM Eastern Time to discuss financial results and companys performance for 2Q20.
The conference call will also be available live on the website www.inspiresleep.com
Earnings Expectation
Inspire Medical Systems, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, INSP is expected to report 2Q20 loss of $ 1.1 per share from revenue of $ 7.85 million.
For the full year, analysts anticipate top line of $ 78.47 million, while looking forward to loss of $ 3.13 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 115.00 million ~ $ 119.00 million
Click Here For More Historical Outlooks Of Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patients breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
